Tech Company M&A Transactions
InnoPharma Acquisition
On 7/16/2014, InnoPharma was acquired by Pfizer. The transaction price was $360 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/16/2014
Transaction Type
M&A
Amount
$360,000,000
M&A Terms
Under the terms of the agreement, Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10 Knightsbridge Road
Piscataway, NJ 08854
USA
Piscataway, NJ 08854
USA
Phone
Website
Email Address
Overview
InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Navneet Puri
Chief Financial Officer
John Deighan
Chief Operating Officer
Sriram Ramanathan
Chief Scientific Officer
Satish Pejaver
Browse more venture capital transactions:
Prev: 7/16/2014: Neon Labs venture capital transaction
Next: 7/16/2014: Shyp venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs